OTC : GNMSF

Genmab A/S

$282 USD

-$3.85 (-1.35%)

Volume
1
Average Volume
1.99K
Market Capitalization
$17.31B
P/E Ratio
21.51
Dividend Yield
0.00%
Price Target
Year High
$352.00
Year Low
$208.80
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.18
Source Headline
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript

Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-14 08:43:03

Get GNMSF Insider Trade Alerts

GNMSF Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

GNMSF Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2023-10-17 HC Wainwright & Co. Maintain Buy Buy
2023-10-12 BTIG Maintain Buy Buy
2023-09-25 Truist Securities Maintain Buy Buy
2023-09-05 Truist Securities Maintain Buy Buy
2023-09-04 HC Wainwright & Co. Maintain Buy Buy
2023-08-14 HC Wainwright & Co. Maintain Buy Buy
2023-08-03 Morgan Stanley Maintain Underweight Underweight
2023-08-03 HC Wainwright & Co. Maintain Buy Buy
2023-07-31 Morgan Stanley Maintain Underweight Underweight
2023-07-30 HC Wainwright & Co. Maintain Buy Buy
2023-07-30 Morgan Stanley Maintain Underweight Underweight
2023-07-23 Morgan Stanley Maintain Underweight Underweight
2023-07-16 Morgan Stanley Maintain Underweight Underweight
2023-07-10 Truist Securities Maintain Buy Buy
2023-06-27 HC Wainwright & Co. Maintain Buy Buy
2023-06-25 HC Wainwright & Co. Maintain Buy Buy
2023-06-25 Morgan Stanley Maintain Underweight Underweight
2023-06-13 HC Wainwright & Co. Maintain Buy Buy
2023-06-05 HC Wainwright & Co. Maintain Buy Buy
2023-05-21 HC Wainwright & Co. Maintain Buy Buy
2023-05-15 HC Wainwright & Co. Maintain Buy Buy
2023-03-01 HC Wainwright & Co. Maintain Buy Buy
2023-02-28 Morgan Stanley Maintain Underweight Underweight
2023-02-22 Morgan Stanley Maintain Underweight Underweight
2023-02-05 SVB Leerink Maintain Market Perform Market Perform
2023-01-23 Morgan Stanley Maintain Underweight Underweight
2022-11-13 Morgan Stanley Maintain Underweight Underweight
2022-11-09 SVB Leerink Maintain Market Perform Market Perform
2022-08-21 HC Wainwright & Co. Maintain Buy Buy
2022-08-14 Morgan Stanley Maintain Underweight Underweight
2022-08-10 SVB Leerink Maintain Market Perform Market Perform
2022-07-19 HC Wainwright & Co. Maintain Buy Buy
2022-05-16 Morgan Stanley Maintain Underweight Underweight
2022-05-11 SVB Leerink Maintain Market Perform Market Perform
2022-04-11 Morgan Stanley Maintain Underweight Underweight
2022-02-16 SVB Leerink Maintain Market Perform Market Perform
2022-01-30 HC Wainwright & Co. Upgrade Neutral Buy
2022-01-02 Guggenheim Downgrade Buy Neutral
2021-09-15 Jefferies Downgrade Buy Hold
2021-09-06 Morgan Stanley Downgrade Equal Weight Underweight
2021-08-23 HC Wainwright & Co. Downgrade Buy Neutral
2021-08-11 Truist Securities Maintain Buy Buy
2021-08-11 SVB Leerink Maintain Market Perform Market Perform
2021-04-18 Morgan Stanley Maintain Equal Weight Equal Weight
2021-02-24 Truist Securities Maintain Buy Buy
2021-02-23 SVB Leerink Maintain Market Perform Market Perform
2021-01-25 SVB Leerink Maintain Market Perform Market Perform
2021-01-18 Morgan Stanley Downgrade Overweight Equal Weight
2021-01-14 HC Wainwright & Co. Maintain Buy Buy
2020-12-15 Morgan Stanley Maintain Overweight Overweight
2020-12-08 SVB Leerink Maintain Market Perform Market Perform
2020-11-24 HC Wainwright & Co. Maintain Buy Buy
2020-11-04 Morgan Stanley Maintain Overweight Overweight
2020-11-04 HC Wainwright & Co. Maintain Buy Buy
2020-10-12 Morgan Stanley Maintain Overweight Overweight
2020-09-22 Bryan Garnier Downgrade Neutral Sell
2020-09-22 HC Wainwright & Co. Maintain Buy Buy
2020-08-23 Truist Securities Maintain Buy Buy
2020-08-20 HC Wainwright & Co. Maintain Buy Buy
2020-08-12 Morgan Stanley Maintain Overweight Overweight
2020-06-18 RBC Capital Maintain Outperform Outperform
2020-06-10 HC Wainwright & Co. Maintain Buy Buy
2020-06-10 SunTrust Robinson Humphrey Maintain Buy Buy
2020-05-31 HC Wainwright & Co. Maintain Buy Buy
2020-05-06 SunTrust Robinson Humphrey Maintain Buy Buy
2020-05-06 HC Wainwright & Co. Maintain Buy Buy
2020-04-14 Morgan Stanley Maintain Overweight Overweight
2020-02-23 HC Wainwright & Co. Maintain Buy Buy
2020-02-19 Morgan Stanley Maintain Overweight Overweight
2019-10-15 HC Wainwright & Co. Maintain Buy Buy
2019-09-11 JP Morgan Upgrade Neutral Overweight